Product Information
ADDERALL XR 30 MG CAPSULE is a brand product labeled by Takeda Pharmaceuticals America, Inc., priced at $6.8085 per EA under NDC 54092039101. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Oct 11, 2001. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
ADDERALL XR 30 MG CAPSULE
Dextroamphetamine Sulfate, Dextroamphetamine Saccharate, Amphetamine Sulfate and Amphetamine AspartateStrength
7.5; 7.5; 7.5; 7.5 mg/1; mg/1; mg/1; mg/1
Manufacturer
Takeda Pharmaceuticals America, Inc.NDC
54092039101
Classification
Brand
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATEApproval Type
New Drug (NDA)
FDA Application
NDA021303FDA Approved
10/11/2001
TE Code
AB1
On Market Since
10/11/2001
Pharmacological Classes
Price Statistics
The NADAC for ADDERALL XR 30 MG CAPSULE has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 2.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.8085 per EA |
|---|---|
| All-time high | $6.9503 (Jul 16, 2014) |
| All-time low | $6.8082 (Jun 17, 2026) |
| 52-week high | $6.8173 |
| 52-week low | $6.8082 |
| Median price | $6.8431 |
| Average price | $6.8572 |
| Largest weekly change | -0.7% (Jan 18, 2017) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 93% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ADDERALL XR 30 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for ADDERALL XR 30 MG CAPSULE, manufactured by Takeda Pharmaceuticals America, Inc., is $6.8085 per EA (NDC 54092039101), effective Aug 19, 2026.
How has the price of ADDERALL XR 30 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for ADDERALL XR 30 MG CAPSULE has declined 2.0%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ADDERALL XR 30 MG CAPSULE?
Since Nov 28, 2013, the NADAC for ADDERALL XR 30 MG CAPSULE has ranged from a low of $6.8082 (Jun 17, 2026) to a high of $6.9503 (Jul 16, 2014), with a median of $6.8431 per EA.
Are there cheaper alternatives to ADDERALL XR 30 MG CAPSULE?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DEXTROAMP-AMPHET ER 30 MG CAP, is $0.4689 per EA — about 93% below ADDERALL XR 30 MG CAPSULE.
Who manufactures ADDERALL XR 30 MG CAPSULE?
ADDERALL XR 30 MG CAPSULE (NDC 54092039101) is labeled by Takeda Pharmaceuticals America, Inc., and CMS classifies it as a brand product.